Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.611 USD | -0.59% | +7.96% | +12.85% |
May. 09 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.85% | 128M | |
+8.43% | 115B | |
+13.04% | 107B | |
-13.63% | 22.31B | |
-3.99% | 21.6B | |
-5.62% | 18.23B | |
-39.93% | 17.62B | |
+7.48% | 14.26B | |
+33.70% | 12.37B | |
-28.22% | 8.28B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- HC Wainwright Cuts Price Target on Sangamo Therapeutics to $3 From $5, Maintains Buy Rating